- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Alliance plans financial restructuring
Outpatient imaging provider Alliance HealthCare Services plans to restructure its debts, offering $200 million aggregate principal amount of seven-year senior notes in a private offering and negotiating and a new senior secured credit agreement with a syndicate of lenders.
Outpatient imaging provider Alliance HealthCare Services plans to restructure its debts, offering $200 million aggregate principal amount of seven-year senior notes in a private offering and negotiating and a new senior secured credit agreement with a syndicate of lenders. The company, which serves more than 1,000 hospitals and other healthcare clients in 45 states, expects the new senior secured credit agreement to include a $450 million term loan with a 6½-year maturity, and a $120 million revolving facility with a five-year maturity. Alliance intends to use the net proceeds of the offering, together with the proceeds from the term loan, to finance the purchase of its outstanding $300 million aggregate principal amount of 7¼% Senior Subordinated Notes due 2012. Remaining proceeds would be used to help refinance Alliance’s existing credit agreement, as well as pay fees and expenses related to the issuance and sale of the notes, the new credit agreement, and the tender offer and consent solicitation.
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.
